LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients…
“The EMA's positive opinion signifies an important step for Soligenix as we continue to advance the program,” says company CEO.…
The company’s core innovation, the HeartBeam System, is positioned as the first cable-free, high-fidelity ECG system capable of capturing the…
Oregon State University researchers have engineered a new nanomaterial from iron that kills cancer cells inside tumors and leaves normal cells unaffected. This…
The promise of immunotherapy lies in its ability to harness the body’s own immune defenses to recognize and destroy malignant…
The media has been awash with stories of intense sweeps by Immigration and Customs Enforcement (ICE) conducted in different cities, such as…
Platform-based drug development has gained traction across the biotechnology industry because of its efficiency and risk management advantages. Soligenix’s development…
Earth Science Tech reported fiscal Q3 2026 revenue of $8.4 million, up 14.1% year over year, with gross margin expanding…
Researchers at Keck Medicine, University of Southern California (USC) have discovered that combining immunotherapy with laser heat therapy could significantly extend…
New report upgrades HeartBeam to buy, raises 12-month price target to $4, citing regulatory progress and company’s transition toward commercialization.…